規格 | 目錄價格 | 上海 | 安徽 | 武漢 | 成都 | 北方 | 深圳 | 會員價格 | 數量 |
---|---|---|---|---|---|---|---|---|---|
250mg | ¥ ????? | > 10 | > 10 | -- | -- | -- | -- | ¥ ????? | - + |
1g | ¥ ?ǐ??? | > 10 | > 10 | -- | -- | -- | -- | ¥ ?ǐ??? | - + |
5g | ¥ ?????? | > 10 | > 10 | -- | -- | -- | -- | ¥ ?????? | - + |
10g | ¥ ?????? | 10 | > 10 | -- | -- | -- | -- | ¥ ?????? | - + |
25g | ¥ ?????? | 4 | > 10 | -- | -- | -- | -- | ¥ ?????? | - + |
100g | ¥ ??????? | 1 | > 10 | -- | -- | -- | -- | ¥ ??????? | - + |
500g | ¥ ?ǐ????? | -- | 3 | -- | -- | -- | -- | ¥ ?ǐ????? | - + |
1kg | ¥ ???????? | -- | 1 | -- | -- | -- | -- | ¥ ???????? | - + |
大貨 | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
產品編號
1034140
CAS 號
51037-30-0
中文名稱
阿西莫司
MDL 號
MFCD00865757
分子量
154.13
存儲條件
2-8°C
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
熔點
177-180 °C
沸點
539.0±45.0 °C at 760 mmHg
閃點
旋光
描述
TPSA
77.13
LogP
-0.27838
H_Acceptors
3
H_Donors
1
Rotatable_Bonds
1
[1]. Ahrén B. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiol Scand. 2001 Feb;171(2):161-7.
[2]. Vestergaard ET, et, al. Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation. Br J Clin Pharmacol. 2017 Dec;83(12):2671-2677.
[3]. Wang-Fisher YL, et, al. Acipimox stimulates leptin production from isolated rat adipocytes. J Endocrinol. 2002 Aug;174(2):267-72.
[4]. B Salgin, et al. Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects. Am J Physiol Endocrinol Metab. 2009 Mar;296(3):E454-61.
[5]. Birgitte Nellemann, et al. Kinetics and utilization of lipid sources during acute exercise and acipimox. Am J Physiol Endocrinol Metab. 2014 Jul 15;307(2):E199-208.
警示圖
警示詞
Warning
危險申明
H302-H315-H319-H335
警告申明
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
GHS 編碼
GHS07
展開更多
現貨供應
專業護航
售后無憂
品質保障
無需湊單